Jeff Fairman

Track

Insider profile

Currently holds a position at Vaxcyte Inc

Positions

Position Company Period
Co-Founder, Vice President - Research Vaxcyte Inc None -
Jeff Fairman's trades of Vaxcyte Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-10-28 2022-10-26
US Vaxcyte Inc (PCVX)
PlS Planned sale
96,038 -48.4%
277.10
US$2,858,428 		96,038 -48.4% 277.10 US$2,858,428
2022-10-13 2022-10-11
US Vaxcyte Inc (PCVX)
PlS Planned sale
58,622 +10.0%
350.89
US$3,404,545 		58,622 +10.0% 350.89 US$3,404,545
2022-09-07 2022-09-06
US Vaxcyte Inc (PCVX)
PlS Planned sale
93,005 +42.7%
335.49
US$1,520,033 		93,005 +42.7% 335.49 US$1,520,033
2022-09-07 2022-09-06
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,664 -1.5%
26.54
US$123,774 		4,664 -1.5% 26.54 US$123,774
2022-08-05 2022-08-05
US Vaxcyte Inc (PCVX)
PlS Planned sale
5,000 -1.6%
25.70
US$128,508 		5,000 -1.6% 25.70 US$128,508
2022-08-05 2022-08-04
US Vaxcyte Inc (PCVX)
PlS Planned sale
10,000 -3.1%
25.50
US$255,000 		10,000 -3.1% 25.50 US$255,000
2022-05-24 2022-05-20
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,112 -1.3%
25.50
US$104,856 		4,112 -1.3% 25.50 US$104,856
2022-05-09 2022-05-05
US Vaxcyte Inc (PCVX)
PlS Planned sale
888 -0.3%
25.80
US$22,914 		888 -0.3% 25.80 US$22,914
2022-04-07 2022-04-05
US Vaxcyte Inc (PCVX)
PlS Planned sale
5,000 -1.5%
25.59
US$127,950 		5,000 -1.5% 25.59 US$127,950
2022-03-15 2022-03-11
US Vaxcyte Inc (PCVX)
PlS Planned sale
10,000 -2.9%
25.50
US$255,000 		10,000 -2.9% 25.50 US$255,000
2021-12-20 2021-12-16
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,619 -42.9%
22.50
US$103,928 		4,619 -42.9% 22.50 US$103,928
2021-12-13 2021-12-09
US Vaxcyte Inc (PCVX)
PlS Planned sale
131 -2.1%
22.50
US$2,948 		131 -2.1% 22.50 US$2,948
2021-10-28 2021-10-26
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,750 -48.0%
22.69
US$107,778 		4,750 -48.0% 22.69 US$107,778
2021-09-29 2021-09-27
US Vaxcyte Inc (PCVX)
PlS Planned sale
139 -2.6%
26.47
US$3,679 		139 -2.6% 26.47 US$3,679
2021-09-29 2021-09-27
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,611 -46.6%
26.16
US$120,624 		4,611 -46.6% 26.16 US$120,624
2021-06-09 2021-06-07
US Vaxcyte Inc (PCVX)
PlS Planned sale
9,500 -64.9%
22.50
US$213,750 		9,500 -64.9% 22.50 US$213,750
2021-03-29 2021-03-26
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,361 -49.2%
24.48
US$33,317 		1,361 -49.2% 24.48 US$33,317
2021-03-29 2021-03-26
US Vaxcyte Inc (PCVX)
PlS Planned sale
3,389 -55.0%
23.64
US$80,116 		3,389 -55.0% 23.64 US$80,116
2021-03-02 2021-02-26
US Vaxcyte Inc (PCVX)
PlS Planned sale
68 -4.6%
25.33
US$1,722 		68 -4.6% 25.33 US$1,722
2021-03-02 2021-02-26
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,372 -48.2%
24.34
US$33,394 		1,372 -48.2% 24.34 US$33,394
2021-03-02 2021-02-26
US Vaxcyte Inc (PCVX)
PlS Planned sale
3,310 -53.8%
23.73
US$78,546 		3,310 -53.8% 23.73 US$78,546
2021-01-28 2021-01-26
US Vaxcyte Inc (PCVX)
PlS Planned sale
425 -23.2%
25.94
US$11,024 		425 -23.2% 25.94 US$11,024
2021-01-28 2021-01-26
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,325 -70.2%
25.20
US$108,990 		4,325 -70.2% 25.20 US$108,990